Skip to main content

Advertisement

Log in

Vitamin D in the Persian Gulf: Integrative Physiology and Socioeconomic Factors

  • Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)
  • Published:
Current Osteoporosis Reports Aims and scope Submit manuscript

Abstract

Countries of the Persian Gulf region—Bahrain, Iran, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates—have become increasingly modernized, resulting in a transformation of lifestyle based on technology, sedentary activity, lack of sunlight, and unhealthy dietary patterns. These factors have led to a higher prevalence not only of vitamin D undernutrition, but also chronic obesity, insulin resistance, prediabetes, and type 2 diabetes. This review explores the integrative physiologic effects of vitamin D with socioeconomic factors and propose a hypothesis-driven model for their contributions to obesity and diabetes in the Persian Gulf. Further research into these interactions may ultimately lead to novel preventive strategies and therapies for metabolic disorders in this geographic region.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Poskitt EME. Countries in transition: underweight to obesity non-stop? Ann Trop Paediatr Int Child Health. 2009;11:1–11.

    Article  Google Scholar 

  2. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010;29:289–301.

    Google Scholar 

  3. American Association of Clinical Endocrinologists. The long awaited Institute of Medicine report on "Dietary Reference Intakes for Calcium and Vitamin D" was released November 30th and is available. Available at: https://www.aace.com/node/205. Accessed March 2011.

  4. Al-Kandari YY. Prevalence of obesity in Kuwait and its relation to sociocultural variables. Obes Rev. 2006;7:147–54.

    Article  PubMed  CAS  Google Scholar 

  5. Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diab Med. 2010;27:593–7.

    Article  CAS  Google Scholar 

  6. Bener A, Zirie M, Musallam M, Khader Y, et al. Prevalence of metabolic Syndrome According to Adult Treatment Panel III and International Diabetes Federation Criteria: A Population-Based Study. Metab Syndr Relat D. 2009;7:221–9.

    Article  Google Scholar 

  7. Weiss AJ, Zaidi M, Mechanick JI. Pharmacological and biological therapies for metabolic bone disease in critical illness: an integrative physiology approach. Curr Drug Ther. 2010;5:48–57.

    Google Scholar 

  8. Weiss AJ, Lipshtat A, Mechanick JI. A systems approach to bone pathophysiology. Ann N Y Acad Sci 2010; 9–24.

  9. Weiss AJ, Iqbal J, Zaidi N, et al. The skeletal subsystem as an integrative physiology paradigm. Curr Osteoporos Rep. 2010;8:168–77.

    Article  PubMed  Google Scholar 

  10. Holick MF. Vitamin D deficiency. NEJM. 2007;357:266–81.

    Article  PubMed  CAS  Google Scholar 

  11. National Academy of Sciences. IOM Report Sets New Dietary Intake Levels for Calcium and Vitamin D To Maintain Health and Avoid Risks Associated With Excess. Available at: http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=13050. Accessed January 2011.

  12. Institute of Medicine of the National Academies. Dietary Reference Intakes for Calcium and Vitamin D. Available at: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Report-Brief.aspx. Accessed January 2011.

  13. Multiple Sclerosis Resource Centre. Vitamin D Research & News. Available at http://www.msrc.co.uk/index.cfm/fuseaction/show/pageid/1334. Accessed May 2011.

  14. • Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-Hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011;31:607–12. This study highlights the recent controversy surrounding vitamin D supplementation guidelines. The study demonstrates the anticancer roles of vitamin D at doses higher than those recommended by the IOM, while raising the lower limit on vitamin D toxicity to 10,000 IU/day.

    PubMed  CAS  Google Scholar 

  15. Vitamin D insufficiency and deficiency in children and adolescents. In: UpToDate. Basow DS, editor. Waltham, MA: UpToDate; 2011.

  16. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol. 2007;103:620–5.

    Article  PubMed  CAS  Google Scholar 

  17. Hagenau T, Vest R, Gissel TN, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009;20:133–40.

    Article  PubMed  CAS  Google Scholar 

  18. Saadi HF, Kazzam E, Ghurbana BA, Nicholls MG. Hypothesis: correction of low vitamin D status among Arab women will prevent heart failure and improve cardia function in established heart failure. Eur J Hear Fail. 2006;8:694–6.

    Article  CAS  Google Scholar 

  19. El-Kaissi S, Sherbeeni S: Vitamin D deficiency in the middle east and its health consequences for adults from nutrition and health. In: Holick MF, editor. Vitamin D. Springer Science; 2010:495–503.

  20. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807–20.

    Article  PubMed  CAS  Google Scholar 

  21. Ghannam NN, Hammami MM, Bakheet SM, Khan BA. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin d status, pregnancy, and lactation. Calcified Tissue Int. 1999;65:23–8.

    Article  CAS  Google Scholar 

  22. Faraj S, Al Mutairi Khalaf. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine. 2003;28:177–9.

    Article  PubMed  Google Scholar 

  23. Hosseinpanah F, Rombad M, Hossein-nejad A, et al. Association between vitamin D and bone mineral density in Iranian postmenopausal women. J Bone Min Metab. 2008;26:86–92.

    Article  CAS  Google Scholar 

  24. Sadat-Ali M, AlElq A, Al-Turki Haifa, et al. Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med. 2009;29:378–81.

    Article  PubMed  Google Scholar 

  25. Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med. 2000;247:260–8.

    Article  PubMed  CAS  Google Scholar 

  26. Gallieni M. Vitamin D: physiology and pathophysiology. Int J Artif Organs. 2009;32:87–94.

    PubMed  CAS  Google Scholar 

  27. Arabi A, Rassi RE, Fuleihan GE. Hypovitaminosis D in developing countries – prevalence, risk factors and outcomes. Nat Rev Endocrinol. 2010;6:550–61.

    Article  PubMed  CAS  Google Scholar 

  28. Poskitt E. Introduction. In: Poskitt E, editor. Management of Childhood Obesity. Cambridge: Cambridge University Press; 2008. p. 1–14.

    Chapter  Google Scholar 

  29. Al-Rethaiaa AS, Fahmy AA, Shwaiyat NM. Obesity and eating habits among college students in Saudi Arabia: a cross sectional study. Nutr J. 2010;9:1–10.

    Article  Google Scholar 

  30. Jarallah Y. Domestic labor in the gulf countries. J Immig Refugee Stud. 2009;7:3–15.

    Article  Google Scholar 

  31. Ramahi TM. Cardiovascular disease in the Asia Middle East region: global trends and local implications. Asia Pac J Public Health. 2010;22:83–9.

    Article  Google Scholar 

  32. Musaiger AO. Socio-cultural and economic factors affecting food consumption patterns in the Arab countries. Perspectives in Public Health. 1993;113:68–74.

    CAS  Google Scholar 

  33. Al-Sarraj T, Saadi H, Volek JS, Fernandez ML. Metabolic syndrome prevalence, dietary intake, and cardiovascular risk profile among overweight and obese adults 18–50 years old from the United Arab Emirates. Metab Syndr Relat Disord. 2010;8:39–46.

    Article  PubMed  CAS  Google Scholar 

  34. Al-Gazali LI, Alwash R, Abdulrazzaq YM. United Arab Emirates: communities and community genetics. Community Genet. 2005;8:186–96.

    Article  PubMed  CAS  Google Scholar 

  35. Al-Sultan FA, Al-Zanki N. Clinical epidemiology of type 2 diabetes Mellitus in Kuwait. Kuwait Med J. 2005;37:98–104.

    Google Scholar 

  36. Yount KM, Sibai AM. Demography of aging in Arab countries. International Handbook of Population Aging. 2009;1:277–315.

    Article  Google Scholar 

  37. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord. 2008;6:177–86.

    Article  PubMed  Google Scholar 

  38. Al-Lawati JA, Al-Hinai HQ, Mohammed AJ, Jousilahti P. Prevalence of the Metabolic Syndrome Among Omani Adults. Diabetes Care 2003; 1781–1785.

  39. Alsaif MA, Hakim IA, Harris RB, et al. Prevalence and risk factors of obesity and overweight in adult Saudi population. Nutr Res. 2001;22:1243–52.

    Article  Google Scholar 

  40. Rasheed P. Perception of body weight and self-reporting eating and exercise behaviour among obese and non-obese women in Saudi Arabia. Public Health. 1998;112:409–14.

    Article  PubMed  CAS  Google Scholar 

  41. FAO. Nutrition Country Profile State of Kuwait. Available at ftp://ftp.fao.org/ag/agn/nutrition/ncp/kwt.pdf. Accessed May 2011.

  42. • Ng SW, Zaghioui S, Ali HI, et al. The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev. 2010;12:1–13. This study is both a unique and recent summary of the prevalence of various metabolic disorders in the Persian Gulf region..

    Article  Google Scholar 

  43. Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:1–9.

    Article  Google Scholar 

  44. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.

    Article  PubMed  CAS  Google Scholar 

  45. • Lou YR, Molnar F, Perakyla M, et al. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2011; In Press. This study uses molecular modeling of the low- and high-affinity conformations of the VDRs to demonstrate the phylogenetically more ancient roles of 25(OH)D compared with its metabolite 1,25 2(OH)D. The study also uses murine and cell models to demonstrate the role 25(OH)D plays in metabolism as well as its antitumor properties.

  46. • Osei K. 25-OH Vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab. 2010;95:4220–2. This study proposes mechanisms to tie vitamin D nutriture to extraskeletal health, such as maintaining glucose homeostasis and mitigating inflammatory processes.

    Article  PubMed  CAS  Google Scholar 

  47. Rosen CJ. Vitamin D insufficiency. NEJM. 2011;364:248–54.

    Article  PubMed  CAS  Google Scholar 

  48. Arunabh S, Pollack S, James Y, Aloia JF. Body fat content and 25-Hydroxyvitamin D Levels in healthy women. Endocrine Care. 2003;88:157–61.

    Article  CAS  Google Scholar 

  49. Garcia OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutr Rev. 2009;67:559–72.

    Article  PubMed  Google Scholar 

  50. Menendez C, Lage M, Peino R, et al. Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue. J Endocrinol. 2001;170:425–31.

    Article  PubMed  CAS  Google Scholar 

  51. Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3 T3-L1 cells. Am J Physiol Endocrinol Metab. 2006;290:916–24.

    Article  Google Scholar 

  52. Ochs-Balcom HM, Chennamaneni R, Millen AE, et al. Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr. 2011;93:5–10.

    Article  PubMed  CAS  Google Scholar 

  53. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26:573–80.

    Article  PubMed  CAS  Google Scholar 

  54. del Pino-Montes J, Benito GE, Fernandez-Salazar MP, et al. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcified Tissue Int. 2003;75:526–32.

    Article  Google Scholar 

  55. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185–97.

    Article  PubMed  CAS  Google Scholar 

  56. Chiu KC, Chu A, Go VLW, et al. Hypovitaminosis D is associated with insulin resistance and β-cell dysfunction. Am J Clin Nutr. 2004;79:820–5.

    PubMed  CAS  Google Scholar 

  57. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.

    Article  PubMed  CAS  Google Scholar 

  58. Thadhani R, Manson JE. Vitamin D for cardiovascular disease prevention in women: state of the evidence. Curr Cardio Risk Rep. 2010;4:216–21.

    Article  Google Scholar 

  59. Zittermann A, Gummert JF. Sun, vitamin D, and cardiovascular disease. J Photochem Photobiol B: Biol. 2010;101:124–9.

    Article  CAS  Google Scholar 

  60. Al-Ghawi A, Uauy R. Study of the knowledge, attitudes and practices of physicians towards obesity management in primary health care in Bahrain. Public Health Nutr. 2009;10:1791–8.

    Article  Google Scholar 

  61. Al-Rashdan I, Al-Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology. 2010;61:42–8.

    Article  PubMed  CAS  Google Scholar 

  62. Musallam M, Bener A, Zirie M, et al. Metabolic Syndrome and its components among Qatari population. Int J Food Saf Nutr Publ Health. 2008;1:88–102.

    Article  Google Scholar 

  63. Al-Nozha MM. Metabolic syndrome in Saudi Arabia. Saudi Med J. 2005;26:1918–25.

    PubMed  Google Scholar 

  64. Baynouna LM, Revel AD, Nagelkerke NJ, et al. High prevalence of the cardiovascular risk factors in Al-Ain, United Arab Emirates. Saudi Med J. 2008;29:1173–8.

    PubMed  Google Scholar 

  65. World Bank. Countries and Economies. Available at: http://data.worldbank.org/country. Accessed December 2010.

Download references

Disclosure

Conflicts of interest: J. Fields: none; N. Trivedi: none; E. Horton: has been on the advisory board for Amylin; has been a consultant for Gilead; has been on the research steering committee for Medtronic; has been on the advisory board and speakers’ bureau for Merck; has been on the advisory board for Roche; has received grant support from Amylin and Eli Lilly; has received honoraria from Amylin, Gilead, Medtronic, Merck, and Roche; and has received travel/accommodations expenses covered or reimbursed from Amylin, Gilead, Medtronic, Merck, and Roche; J.I. Mechanick: has been a consultant, received honoraria, received payment for development of educational presentations including service on speakers’ bureaus, and received travel/accommodations expenses covered or reimbursed by Abbott Nutrition and Nestle Nutrition; and has received grant support from Select Medical Corporation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey I. Mechanick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fields, J., Trivedi, N.J., Horton, E. et al. Vitamin D in the Persian Gulf: Integrative Physiology and Socioeconomic Factors. Curr Osteoporos Rep 9, 243–250 (2011). https://doi.org/10.1007/s11914-011-0071-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11914-011-0071-2

Keywords

Navigation